Alterations in immune function have been implicated in the aetiopathogenesis of schizophrenia. Specifically, the induction of inflammatory cytokines, which are important immunological factors in infection or inflammation, may be critical factors altering the normal course of brain development and increasing schizophrenia risk. Suppressor of cytokine signalling 2 (SOCS2) can negatively regulate the signalling of cytokines. The present study aimed to determine the behavioural phenotype of transgenic mice over-expressing SOCS2 (SOCS2 Tg) in paradigms of relevance to schizophrenia. Both male and female SOCS2 Tg mice displayed reduced locomotor hyperactivity after the administration of the dopamine releaser, amphetamine, compared to wildtype controls (WT). However, only male SOCS2 Tg mice showed enhanced prepulse inhibition compared to WT. Dopamine D2 receptors mRNA expression was reduced and dopamine transporter mRNA expression was increased in the nucleus accumbens of female, but not male, SOCS2 Tg mice, compared to WT. The role of hyperdopaminergia has long been implicated in the aetiology of schizophrenia. This study shows that over-expression of SOCS2 reduces the psychostimulant effects of amphetamine, enhances PPI, and alters mesolimbic dopaminergic activity. SOCS2 may provide a novel target in the development of treatments for schizophrenia.
Introduction
Schizophrenia is a neurodevelopmental disorder, thought to originate from aberrations in brain development during early foetal and postnatal stages. There is increasing evidence for the role of the immune system in the aetiopathogenesis of schizophrenia (Miller et al., 2011; Nawa and Takei, 2006; Patterson, 2009; Potvin et al., 2008) . Of particular interest is the abnormal expression of inflammatory cytokines, a common response by the immune system to varying infections. For example, epidemiological studies, that found an increased incidence of schizophrenia in individuals exposed to a bacterial or viral infection during prenatal life, indicate that a critical factor altering normal brain development is an induction of inflammatory cytokines (Brown et al., 2004; Buka et al., 2001 ). In addition, abnormalities in the constitutive expression of inflammatory cytokines, such as interleukin (IL)-6, IL-8 and IL-10, have been found in the serum of schizophrenic patients (Maes et al., 2002; Potvin et al., 2008) .
The Janus kinases (JAK) and signal transducers and activators of transcription (STAT) signalling pathway has an important role in driving biological responses to cytokines (Rawlings et al., 2004) . Factors that regulate the JAK-STAT pathway, and thus mediate cytokine signalling, may also provide a novel target for treatment of schizophrenia. The primary function of a family of eight proteins, called suppressor of cytokine signalling (SOCS), is to negatively regulate the JAK-STAT pathway via a negative feedback loop, and therefore suppress the signalling of cytokines (Piessevaux et al., 2008) .
Of the eight SOCS family proteins, SOCS2 is one of the more extensively studied. SOCS2 is well characterised as an inhibitor of growth hormone signalling, however, it has now also been found to regulate signalling of various other growth factors and cytokines (Goldshmit et al., 2004a,b; Greenhalgh et al., 2002; Jegalian and Wu, 2002; Metcalf et al., 2000; Rico-Bautista et al., 2006; Uren and Turnley, 2014; Wang et al., 2004) . We have previously found that transgenic mice that overexpress SOCS2 (SOCS2 Tg) display an enhanced survival of newly-born adult hippocampal neurons. Additionally, these mice show enhanced exploratory activity and less anxiety in novel environments (Ransome and Turnley, 2008) . In contrast, animal models of
